Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lots of reasons people decide to sell.
Jtf don’t forget the transient neuropathy! Oldie but goodie
“ New data supporting Brilacidin’s broad spectrum antiviral properties will be presented at the 2021 MHSRS conference, ” this is my favorite part!
Don’t overlook the $44b anti-viral market opportunity.
90% done with the trial and no concerns yet!
After all the trials B has been involved with they were given fast track for covid and then were allowed to expand their dosing from 3 days to 5 days! Yes that means that the fda had no safety concerns at that point. “ IPIX) none of these SAEs were caused by brilacidin” couldn’t say it better myself!
Focus.... there have been no serious sae’s associated with B. Period
History class with tiab! Just as meaningless and boring now as it was in high school
His hatred has caused him to be wrong a lot!
Awesome post! Thanks
End of June beginning of July
I am not sure what your point is but if a person doesn’t like management or science and they stay invested only to heckle other investors there is something really wrong with them!
I not buying that either non-investors or disillusioned long investors are sharing their feelings for no reason.
Interesting article on masks.
https://swprs.org/face-masks-evidence/?amp&__twitter_impression=true
I agree!
I am sure we will have top line before that
Let’s see the fda granted fast track based on RBL data and previous trial success and safety. FDA approved dosing increase based on current trial safety.... looks like the fda is eager to see B trial results.
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30444-7/fulltext
It really depends doesn’t it. Also the inflammatory properties seem to be another key. 3-1 baby!
You mean it’s not a 3-1 solution that has antibiotic and anti-inflammatory properties in addition to antiviral properties like B!
Just compare what happened with cydy to see how they have mismanaged their relationship with fda.
Or tell that to Japan and many of the other island nations!
https://time.com/6046172/southeast-asia-covid/
“ denied the 4 dose regimen” did they safety issues? I am glad B didn’t have any past safety issues and was able to have a dosing increase built into our trial!
Tell that to India!
Top line results before conference
Great news
Complete bs! “ Covid trial will likely never be completed. ” But I guess it’s silly Sunday on ipix!
Nice post thank you
No it doesn’t work that way! You and max made the statement you ask
Max made the statement now I want to see the evidence otherwise I will assume it’s a false statement
Please provide evidence Leo has been on these boards!!!
You never did provide any evidence
Please provide evidence or we will assume the statement is false!!!
Please provide evidence
Complete bs! This has been proven false.
Lots! Lol
How many of the covid 19 therapeutics that have not done so well had independent research and articles published in journals? And I should of mentioned where highly touted!
Provide a link showing they are unloading shares!
You’re right they are not just an investor they are a major investor go IPix